CXCL1 stimulates decidual angiogenesis via the VEGF-A pathway during the first trimester of pregnancy
- 26 March 2021
- journal article
- research article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 476 (8) , 2989-2998
Abstract
Angiogenesis is critical to establishing a successful pregnancy. The chemokine (C-X-C motif) ligand 1 (CXCL1) is a small cytokine belonging to the CXC chemokine family that is an important chemokine involved in the processes of angiogenesis and arteriogenesis; however, little is known about its role in decidual angiogenesis. Effects of CXCL1 on cell proliferation and migration (propidium iodide staining and wound healing assays) of HUVEC cells were determined. The angiogenesis roles of CXCL1 in HUVEC-HTR8/SVneo co-culture system were detected by the tube formation assay. Signal transduction pathways in HUVEC cells in response to CXCL1 were determined by in-cell western analyses. In vivo, mice were injected with (1) PBS (Group A) or (2) CXCL1-neutralizing antibody (Group B) or (3) CXCL1-neutralizing antibody plus recombinant VEGF-A protein (Group C) from E1 to E5 and sacrificed at E6.5 of pregnancy. The decidual angiogenesis in mice was examined by immunohistochemistry of cluster designation 34 (CD34), and the expression levels of vascular endothelial growth factor-A (VEGF-A) in the decidual cells and vascular endothelial growth factor receptor 2 (VEGFR2) in decidual vascular endothelial cells were also tested. Exogenous recombinant human CXCL1 supported endothelial cell proliferation and migration, and this effect was blocked by CXCL1-neutralizing antibody or CXCR2 inhibitor SB265610. The tube formation of HUVEC-HTR8/SVneo co-culture system was significantly stimulated by CXCL1, but this effect was markedly abrogated once they were pretreated with CXCL1-neutralizing antibody or CXCR2 inhibitor SB265610. In addition, the level of vascular endothelial growth factor A (VEGF-A) expression in HUVEC cells was increased by CXCL1, and this level was suppressed by CXCL1-neutralizing antibody or CXCR2 inhibitor SB265610. In vivo, compared with Group A (n = 3), decidual angiogenesis was significantly reduced in Group B by CD34 immunostaining. But compared with Group B, decidual angiogenesis was significantly increased in Group C. In addition, the expression of VEGF-A and VEGFR2 was significantly increased after neutralizing of CXCL1 in Group B. In conclusions, CXCL1 may play essential roles in decidual angiogenesis during the first trimester, and this function may be mediated in part via altering VEGF-A expression.Keywords
Funding Information
- Natural Science Foundation of Liaoning Province (2018225087)
- Natural Science Foundation of Liaoning Province (2019-ZD-1093)
- Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Project (RC180301)
This publication has 27 references indexed in Scilit:
- Bronchial Smooth Muscle Cells of Asthmatics Promote Angiogenesis through Elevated Secretion of CXC-Chemokines (ENA-78, GRO-α, and IL-8)PLOS ONE, 2013
- CXCL1 expression in human decidua in vitro is mediated via the MAPK signalling cascadeCytokine, 2013
- VEGF‐A regulated by progesterone governs uterine angiogenesis and vascular remodelling during pregnancyEMBO Molecular Medicine, 2013
- The chemokine CXCL6 restricts human trophoblast cell migration and invasion by suppressing MMP-2 activity in the first trimesterHuman Reproduction, 2013
- Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesisBasic Research in Cardiology, 2012
- Paracrine effects of uterine leucocytes on gene expression of human uterine stromal fibroblastsMolecular Human Reproduction, 2008
- Decidual Stromal Cell Response to Paracrine Signals from the Trophoblast: Amplification of Immune and Angiogenic Modulators1Biology of Reproduction, 2007
- CXC chemokines: the regulatory link between inflammation and angiogenesisTrends in Immunology, 2004
- INHIBITION OF GROα-INDUCED HUMAN ENDOTHELIAL CELL PROLIFERATION BY THE α-CHEMOKINE INHIBITOR ANTILEUKINATECytokine, 1999
- Angiogenic FactorsScience, 1987